A dministration of packed red blood cells (PRBCs) has been associated with morbidity and mortality for both medical and surgical patients (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Transfusions are associated with transmission of infectious agents (5) , postoperative infectious complications (4, 10, 13) , sternal wound infections (1), postoperative pneumonia (11) , renal dysfunction (6) , impaired postoperative pulmonary function (3), multiple organ failure (7) , increased intensive care unit (4, 9, 10) and hospital length of stay (4, 9) , and increased short- (2, 8) and long-term mortality (12) . Gong et al. (14) recently demonstrated the association between PRBC transfusion and the development and increased mortality from acute respiratory distress syndrome. As little as a 1-unit transfusion of PRBC was associated with increased mortality.
Previous investigations have been limited by examining PRBC transfusion as a binary variable (1, 12) , thereby limiting examination of a dose-dependent effect, have not included both intraoperative and postoperative PRBC transfusions (1), or have not included the influence of blood components such as platelets, fresh frozen plasma, and cryoprecipitate (4, (7) (8) (9) 12) . Previous investigations have examined heterogenous patient populations (2, 4, 7, 9) such as mixed surgical, medical (2, 4) , or trauma patients (7, 9) . Furthermore, there is heterogeneity within the cardiac surgical literature with the inclusion of mixed valve and coronary artery bypass grafting (CABG) patients who often have different transfusion requirements. Finally, a number of investigations have examined a single morbid outcome and have been limited by sample size.
Our objectives were 1) to examine whether each unit of PRBC transfused perioperatively conferred incrementally increased risk for mortality and major morbid outcomes in a large homogeneous cohort of patients undergoing isolated CABG and 2) to identify patient and procedure-related variables associated with the need for PRBC transfusion.
MATERIALS AND METHODS

Patients and Data
Between January 1, 1995, and July 1, 2002, 11,963 patients underwent isolated CABG at the Cleveland Clinic Foundation. Perioperative variables and blood-component utilization forms were prospectively collected concurrently with patient care and entered into the Cardiothoracic Anesthesia Registry. Patients receiving aspirin or clopidogrel had these medications discontinued approximately 7 days before surgery. The database has been approved for research by our institutional review board.
End Points
Postoperative mortality was defined as an in-hospital death. Cardiac morbidity consisted of a low cardiac index (Ͻ1.8 L · min Ϫ1 · m Ϫ2 ) despite adequate fluid replacement and highdose inotropic agents for Ͼ4 hrs or a postoperative myocardial infarction with at least one of the following: an intraaortic balloon pump, intraoperative placement of a temporary or permanent right or left ventricular assist device or extracorporeal membrane oxygenator, or preoperative placement of intraaortic balloon pump. Neurologic morbidity included focal or global neurologic deficits or death without awakening. Serious infection morbidity consisted of sepsis syndrome, septic shock, pneumonia, or mediastinitis. In addition, the diagnosis of sepsis included organisms isolated from the cultures along with elevated temperature and white blood cell counts. Prolonged postoperative ventilatory support was defined as mechanical ventilatory support for Ն72 hrs postoperatively. Renal morbidity consisted of newonset renal failure requiring dialysis. Overall morbidity was one or more of the above morbidities.
Statistical Methods
Baseline univariate comparisons between those transfused and not transfused PRBC were made with Wilcoxon's rank-sum and the chi-square tests where appropriate.
Modeling Morbidity and Red Blood Cell Transfusion. Logistic regression was used to model the probability of in-hospital mortality and cardiac, neurologic, serious infection, prolonged ventilatory support, renal and overall morbidity as a function of PRBC and bloodcomponent transfusion. The scale of PRBC transfusion was truncated at 10 units; because of sparse data, platelet, cryoprecipitate, and fresh frozen plasma data were grouped into binary variables. To assess and adjust for patient and procedure variables, the analysis considered all variables in Table 1 and the date of operation. Linearizing transformations of continuous variables were utilized as required to meet the assumption of the logistic model.
Bootstrap aggregation (bagging) (15) of automated analysis of bootstrap data sets with a retention criterion of p Ͻ .05 was used for variable selection. Variables selected more than one third of the time were considered potentially significantly associated with the outcome and were submitted to a final run of logistic regression. The list of variables was further reduced by backward elimination of those with p values of Ͼ.05. Interaction terms between blood products and other significant variables were successively added; none were found to contribute significantly to the model.
To gain further insight into the association of PRBCs on postoperative outcomes, the logistic regression model was further adjusted by a balancing score from all variables contained in Table 1 (16) . The balancing score was calculated for each patient from a negative binomial regression of PRBC units (ranging from 0 to 91). Thus, the balancing score represents a numerical summarization of all baseline characteristics associated with transfusion of PRBC. The balancing score was forced in as a covariate for the logistic regression model on postoperative morbidities and in-hospital mortality. After covariate adjustment with the balancing score, the coefficient of PRBCs in the logistic regression can be interpreted as being the independent effect of PRBCs, when all other baseline characteristics are similar.
Modeling Predictors of Red Blood Cell Transfusion. A logistic regression model was developed to identify patient and procedure variables that were associated with PRBC transfusion. The baseline variables in Table 1 
RESULTS
Preoperative and operative characteristics by transfusion status are listed in Table 1 . Of the 11,963 patients, 5,184 (49%) received Ն1 unit of PRBCs intraoperatively and postoperatively, with the most common number being 2 units (Fig. 1) . Among the 20,513 units of PRBCs transfused, 9336 units (46%) were given in the operating room and 11,177 PRBC units (54%) were transfused in the intensive care unit. Platelets were transfused in 9.8%, fresh frozen plasma in 2.4%, and cryoprecipitate in 0.45% of patients.
Morbidity and Transfusion
Mortality. Overall in-hospital mortality for patients not transfused was 0.05% and 3.07% for those transfused PRBCs, respectively. There was a dose-dependent relationship between each unit of PRBC transfused and unadjusted and adjusted Table 2 . A number of traditional risk factors associated with postoperative mortality such as advanced age, female sex, low preoperative hematocrit, small body size, and reoperation were not significantly related to postoperative mortality once units of PRBCs were taken into account.
Morbidity. Postoperative morbid events for those not transfused and transfused PRBCs were the following: renal morbid events, 0% and 1.81%; prolonged ventilatory support, 0.44% and 9.14%; serious postoperative infection, 0.24% and 5.03%; cardiac morbidity, 0.05% and 3.03%; neurologic morbidity, 0.37% and 2.41%; and overall postoperative morbidity, 0.96% and 12.33%, respectively. Each unit of PRBCs transfused was associated with a Ͼ100% (OR, 2.06; 95% CI, 1.87-2.27; p Ͻ .0001) increased odds for postoperative renal morbidity, a 79% (OR, 1.79; 95% CI, 1.72-1.86; p Ͻ .0001) increased odds for postoperative ventilatory support beyond 72 hrs, a 76% (OR, 1.76; 95% CI, 1.68 -1.84; p Ͻ .0001) increased odds for a serious postoperative infection, a 55% (OR, 1.55; 95% CI, 1.47-1.63; p Ͻ .0001) increase in the odds for postoperative cardiac morbidity, a 37% (OR, 1.37; 95% CI, 1.30 -1.44; p Ͻ .0001) increase in the odds for postoperative neurologic morbidity and a 73% (OR, 1.73; 95% CI, 1.67-1.80; p Ͻ .0001) increase in the odds for overall postoperative morbidity (Figs. 3 and 4) . Additional risk factors for the individual postoperative morbid events are listed in Tables 3-8 . Operative date (date of surgery) was not significant for five of the seven models. It was significant for intubation morbidity (OR ϭ 0.94, p ϭ .03) and overall morbidity (OR ϭ 0.95, p ϭ .05). These results imply that the risk for the outcome decreases over years.
Factors Related to Red Blood Cell Transfusion
The absence of some traditional risk factors that have been associated with increased risk of postoperative events is explained by their strong association with transfusion. Older, smaller patients with low preoperative hematocrit and those undergoing reoperative surgery were at high risk of receiving PRBC transfusion (Appendix 1). Figure 4 displays the relationship between increasing age, smaller body mass index, decreasing preoperative hematocrit, longer aortic clamp time, and the probability of receiving a PRBC transfusion.
DISCUSSION
Principal Findings
We report that transfusion of PRBCs is associated with a dose-dependent increased risk for postoperative cardiac complications, serious infection, renal failure, neurologic complications, overall morbidity, prolonged ventilatory support, and in-hospital mortality after isolated CABG. This association remained strong even after adjusting for risk factors known to be associated with adverse outcome after CABG. In every logistic model, transfusion of PRBCs was the most reliable predictor associated with adverse outcome as it was chosen 100% of the time in the bootstrap bagging procedure.
Rao et al. (17) recently reported on the association of blood transfusion and mortality in the setting of anemia during hospitalization for acute coronary syndromes. Patients who received at least one blood transfusion during their hospitalization had a risk-adjusted increase in the hazard for 30-day death. In a prospective multicenter observational inves- tigation, Vincent et al. (2) examined the prevalence of anemia and PRBC usage in 1,136 critically ill patients. Transfused patients had higher mortality rates at every admitting hemoglobin level when compared with nontransfused patients. Similarly, in a multicenter observational cohort of intensive care unit patients, Corwin et al. (18) reported an association between PRBC units transfused and worse clinical outcome. However, in a recent investigation, Wu et al. (19) reported that blood transfusion was associated with reduced short-term mortality among elderly patients with acute myocardial infarction and with admission hematocrits of Ͻ30%.
The association between transfusion and adverse postoperative morbid outcomes has been consistent in the cardiac surgical literature. Leal-Noval et al. (10) reported a risk-adjusted increase in severe postoperative infections for patients who received transfusion of Ն4 units of blood components. Transfused patients had higher postoperative mortality and a longer mean intensive care unit stay as compared with those not transfused. Chelemer et al. (13) reported a dosedependent increase in the rate of bacterial infections for transfused cardiac surgical patients: 4.8% for no transfusion, 15% for 1-2 units, 22% for 3-5 units, and 29% for Ն6 units transfused. It has been speculated that the leukocyte-mediated immunosuppressive effects of transfusion may contribute to the increased risk of infection (13, 20, 21) . Vamvakas and Carven (3) examined the relationship between transfusion and need for prolonged ventilatory support after cardiac surgery. Volume of PRBC supernatant was associated with a risk-adjusted increase in the likelihood of postoperative ventilation past the day of operation, suggesting that the adverse effect of PRBC transfusion was probably mediated by the supernatant fluid of stored PRBCs.
Whether PRBC transfusions caused the observed adverse outcomes or was a surrogate marker for a sicker patient cannot be determined with certainty from this analysis. However, by modeling a current set of predictors for morbid outcomes in this patient population, we were able to adjust for those variables known to contribute to a sicker patient profile. The addition of a balancing score to all seven models additionally adjusted for biases related to why a patient received a transfusion. (29) . The extent of a patient's inflammatory response is related to intrinsic patient-related factors, cardiopulmonary bypass, and allogenic blood transfusion during cardiac surgery (24). Fransen et al. (24) demonstrated that intraoperative transfusion PRBCs affects the release of inflammatory mediators in patients undergoing cardiac surgery by enhancing part of the inflammatory response and by direct transfusion of bioactive substances. Furthermore, although they examined only 114 patients, they reported longer intubation times and intensive care unit length of stay for those who received an intraoperative transfusion.
Adverse immunomodulatory effects of blood transfusion may also contribute to the observed outcomes in our patient population (30) . There is evidence to sup- a All variables in Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1; c creatinine was square-root transformed. (34, 35) . The optimal range of hematocrit values that balances the associated complications of blood transfusion with complications related to anemia are unknown. Habib et al. (36) reported that the lowest hematocrit value on cardiopulmonary bypass (Ͻ22%) was associated with increased morbidity and was predictive of worse 0-to 6-yr survival. They speculated that hemodilution severity during bypass was associated with worse perioperative organ dysfunction from inadequate oxygen delivery at low hematocrits. Although Wu et al. (19) described a benefit for PRBC transfusion in patients who were elderly and had low admission hematocrit values (Ͻ30%), they also reported that for those patients with hematocrit values of Ն36% and who received PRBC transfusions had a higher risk of death within 30 days than patients with a similar hematocrit who did not receive blood. Interestingly, in a randomized, controlled trial of 838 critically ill ICU patients, Hebert et al. (37) reported similar overall 30-day mortality for a restrictive transfusion strategy (hemoglobin levels maintained between 7 and 9 g/dL) vs. a more liberal transfusion strategy (hemoglobin levels maintained between 10 and 12 g/dL). Although mortality was similar in the two groups, it was significantly lower with the restrictive strategy among patients who were less acutely ill.
Other Risk Factors for Outcome. The large sample size of 11,963 isolated CABG patients allowed us to examine a number of factors in addition to blood transfusion that were related to postoperative morbidity and mortality by modeling the seven individual outcomes. The influence of demographics, co-morbid conditions, patient-related disease characteristics, laboratory values, and operative variables, not unexpectedly, were variably associated with individual postoperative morbidities and mortality. Regardless of the individual model, transfusion of PRBCs was significantly associated with adverse outcome in every model (Tables 2-8) .
Predictors for Perioperative Transfusion
Reoperation (31, 38, 39) , age (31, 32, 39) , female sex (32, 33, 39) , preoperative hematocrit (31-33, 38, 39) , decreased ejection fraction (31, 38) , preoperative serum creatinine (of Ն1.3 mg/dL) (40), and Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1; c square-root transformation was used. a All variables in Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1. OR, odds ratio; CL, confidence limits; PRBC, packed red blood cells; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.
a All variables in Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1.
low body weight (32, 33) are variables that have been identified as factors related to an increased risk for blood transfusion from previous investigations. We similarly report that reoperation, older age, lower preoperative hematocrit, lower body mass index, and measures of renal dysfunction such as increased preoperative blood urea nitrogen were among a number of predictors for red blood transfusion in our patient population (Appendix 1, Table 1 ).
Study Limitations
This was a nonrandomized study in which unmeasured patient or procedurerelated variables may have influenced the study results. Furthermore, this investigation was conducted at a large tertiary referral center, and the results may not be broadly representative of community practice. The examination of a homogeneous patient population of isolated CABG patients and the incorporation of a balancing score into the analyses addressed variability in indications for transfusion. The effectiveness of a balancing score depends on using measured variables strongly associated with unmeasured variables influencing the decision to transfuse. There was no set hematocrit value that triggered a transfusion for patients. However, most transfused patients most commonly received only 1 or 2 units of PRBCs, amounts that are not commonly associated with excessive blood loss. Information regarding length of storage of blood products was unavailable for the individual patient. Increased length of storage for PRBCs has been associated with an increased risk for postinjury multiple organ failure (41) . In addition, information on whether PRBCs were leukocyte reduced was also unavailable. However, universal leukocyte depletion was not instituted at our institution until 2002. It has been reported that tumor necrosis factor, interleukin (IL)-1, IL-6, and IL-8 in stored PRBCs exhibit considerable variability over the storage period and between units (42) . Prestorage white cell filtration of cytokine content in PRBCs diminishes the amount of IL-1, IL-6, IL-8, and tumor necrosis factor-␣ during storage (43) . There has been evidence that documents the efficacy of leukocyte depletion for reducing the prevalence of complications related to allogeneic blood transfusion (44 -46) .
Among the strengths of this investigation is the large homogeneous cohort of patients, an extensive prospectively collected list of preoperative, laboratory, and operative variables, and a detailed record of operative and postoperative PRBCs, platelets, fresh frozen plasma, and cryoprecipitate transfused.
Clinical Implications
Despite this negative association between PRBC transfusion and morbid out- a All variables in Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1. a All variables in Table 1 were considered in variable selection procedures; b factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1. OR, odds ratio; CL, confidence limits; PRBC, packed red blood cells; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; ITA, internal thoracic artery grafting.
a All variables in Table 1 were considered in variable selection procedures; factors associated with increased risk of the complication will have an odds ratio of Ͼ1, and those associated with a decreased risk will have an odds ratio of Ͻ1.
comes, a large percentage of patients who undergo CABG are transfused PRBCs in the perioperative period. Considerable variability exists for transfusion of PRBCs (47, 48) , despite published guidelines (49 -51) . In a multicenter study of 2,417 CABG patients, rates of PRBC transfusion ranged between 27% and 92% (51) . The decision to transfuse PRBCs and components of blood is often multifactorial and may be related to preoperative anemia, hemorrhage, or beliefs of the anesthesiologist, surgeon, or intensivist. A recent investigation of isolated CABG patients demonstrated that despite similar preoperative hemoglobin, blood volume estimates, co-morbid conditions, and operations, more women were transfused than men for no apparent reason (52) . Others have reported on the lack of clear indications for transfusion of blood products (53) .
Our results demonstrate substantial and incremental increases in risk associated with PRBC transfusion for every morbid outcome in this large homogeneous patient population. The mechanism associated with transfusion and adverse outcome remains unknown. Better identification of groups at high risk for transfusion and potentially modulating this risk through interventions such as optimizing the preoperative hematocrit, meticulous attention to crystalloid administration, and reexamining the hematocrit threshold for perioperative transfusion may contribute to a reduction in perioperative PRBC transfusion. The application of these interventional blood conservation measures, in particular for the majority of patients who would commonly receive only 1 or 2 PRBC units, may circumvent the need for transfusion.
CONCLUSIONS
Older, smaller patients with low preoperative hematocrit and those undergoing reoperative surgery were transfused most often. Transfusion of PRBCs was associated with a dose-dependent, riskadjusted increase in the occurrence of every postoperative morbidity and mortality outcome after isolated CABG. We report a strong association between PRBC transfusion and the observed excess complications; however, it is impossible in our analysis to completely eliminate the possibility that transfusion requirement was a marker for sicker patients or more extensive surgery. But given the apparent risk, our results suggest that transfusions should be avoided to the extent possible. CL, confidence limit; BMI, body mass index; BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association functional classification; IABP, intraaortic balloon pump.
a The variable was square-root transformed before being submitted to logistic regression.
